Erythropoietin Stimulating Agents Market, Global Outlook and Forecast 2023-2028

Report ID: 1632999 | Published Date: Jan 2025 | No. of Page: 65 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Erythropoietin Stimulating Agents Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Erythropoietin Stimulating Agents Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Erythropoietin Stimulating Agents Overall Market Size
    2.1 Global Erythropoietin Stimulating Agents Market Size: 2021 VS 2028
    2.2 Global Erythropoietin Stimulating Agents Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Erythropoietin Stimulating Agents Players in Global Market
    3.2 Top Global Erythropoietin Stimulating Agents Companies Ranked by Revenue
    3.3 Global Erythropoietin Stimulating Agents Revenue by Companies
    3.4 Top 3 and Top 5 Erythropoietin Stimulating Agents Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Erythropoietin Stimulating Agents Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Erythropoietin Stimulating Agents Players in Global Market
        3.6.1 List of Global Tier 1 Erythropoietin Stimulating Agents Companies
        3.6.2 List of Global Tier 2 and Tier 3 Erythropoietin Stimulating Agents Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Erythropoietin Stimulating Agents Market Size Markets, 2021 & 2028
        4.1.2 Epoetin Alfa
        4.1.3 Epoetin Beta
        4.1.4 Darbepoetin Alfa
        4.1.5 Others
    4.2 By Type - Global Erythropoietin Stimulating Agents Revenue & Forecasts
        4.2.1 By Type - Global Erythropoietin Stimulating Agents Revenue, 2017-2022
        4.2.2 By Type - Global Erythropoietin Stimulating Agents Revenue, 2023-2028
        4.2.3 By Type - Global Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Erythropoietin Stimulating Agents Market Size, 2021 & 2028
        5.1.2 Hospitals
        5.1.3 Clinics
        5.1.4 Others
    5.2 By Application - Global Erythropoietin Stimulating Agents Revenue & Forecasts
        5.2.1 By Application - Global Erythropoietin Stimulating Agents Revenue, 2017-2022
        5.2.2 By Application - Global Erythropoietin Stimulating Agents Revenue, 2023-2028
        5.2.3 By Application - Global Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Erythropoietin Stimulating Agents Market Size, 2021 & 2028
    6.2 By Region - Global Erythropoietin Stimulating Agents Revenue & Forecasts
        6.2.1 By Region - Global Erythropoietin Stimulating Agents Revenue, 2017-2022
        6.2.2 By Region - Global Erythropoietin Stimulating Agents Revenue, 2023-2028
        6.2.3 By Region - Global Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Erythropoietin Stimulating Agents Revenue, 2017-2028
        6.3.2 US Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.3.3 Canada Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.3.4 Mexico Erythropoietin Stimulating Agents Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Erythropoietin Stimulating Agents Revenue, 2017-2028
        6.4.2 Germany Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.4.3 France Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.4.4 U.K. Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.4.5 Italy Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.4.6 Russia Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.4.7 Nordic Countries Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.4.8 Benelux Erythropoietin Stimulating Agents Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Erythropoietin Stimulating Agents Revenue, 2017-2028
        6.5.2 China Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.5.3 Japan Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.5.4 South Korea Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.5.5 Southeast Asia Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.5.6 India Erythropoietin Stimulating Agents Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Erythropoietin Stimulating Agents Revenue, 2017-2028
        6.6.2 Brazil Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.6.3 Argentina Erythropoietin Stimulating Agents Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Erythropoietin Stimulating Agents Revenue, 2017-2028
        6.7.2 Turkey Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.7.3 Israel Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.7.4 Saudi Arabia Erythropoietin Stimulating Agents Market Size, 2017-2028
        6.7.5 UAE Erythropoietin Stimulating Agents Market Size, 2017-2028
7 Players Profiles
    7.1 Pfizer
        7.1.1 Pfizer Corporate Summary
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Erythropoietin Stimulating Agents Major Product Offerings
        7.1.4 Pfizer Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
        7.1.5 Pfizer Key News
    7.2 Amgen
        7.2.1 Amgen Corporate Summary
        7.2.2 Amgen Business Overview
        7.2.3 Amgen Erythropoietin Stimulating Agents Major Product Offerings
        7.2.4 Amgen Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
        7.2.5 Amgen Key News
    7.3 BioSidus
        7.3.1 BioSidus Corporate Summary
        7.3.2 BioSidus Business Overview
        7.3.3 BioSidus Erythropoietin Stimulating Agents Major Product Offerings
        7.3.4 BioSidus Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
        7.3.5 BioSidus Key News
    7.4 Biocon
        7.4.1 Biocon Corporate Summary
        7.4.2 Biocon Business Overview
        7.4.3 Biocon Erythropoietin Stimulating Agents Major Product Offerings
        7.4.4 Biocon Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
        7.4.5 Biocon Key News
    7.5 Celltrion
        7.5.1 Celltrion Corporate Summary
        7.5.2 Celltrion Business Overview
        7.5.3 Celltrion Erythropoietin Stimulating Agents Major Product Offerings
        7.5.4 Celltrion Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
        7.5.5 Celltrion Key News
    7.6 Roche
        7.6.1 Roche Corporate Summary
        7.6.2 Roche Business Overview
        7.6.3 Roche Erythropoietin Stimulating Agents Major Product Offerings
        7.6.4 Roche Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
        7.6.5 Roche Key News
    7.7 Intas Pharmaceuticals
        7.7.1 Intas Pharmaceuticals Corporate Summary
        7.7.2 Intas Pharmaceuticals Business Overview
        7.7.3 Intas Pharmaceuticals Erythropoietin Stimulating Agents Major Product Offerings
        7.7.4 Intas Pharmaceuticals Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
        7.7.5 Intas Pharmaceuticals Key News
    7.8 Johnson and Johnson
        7.8.1 Johnson and Johnson Corporate Summary
        7.8.2 Johnson and Johnson Business Overview
        7.8.3 Johnson and Johnson Erythropoietin Stimulating Agents Major Product Offerings
        7.8.4 Johnson and Johnson Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
        7.8.5 Johnson and Johnson Key News
    7.9 Teva Pharmaceutical Industries
        7.9.1 Teva Pharmaceutical Industries Corporate Summary
        7.9.2 Teva Pharmaceutical Industries Business Overview
        7.9.3 Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Major Product Offerings
        7.9.4 Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
        7.9.5 Teva Pharmaceutical Industries Key News
    7.10 Thermo Fisher Scientific
        7.10.1 Thermo Fisher Scientific Corporate Summary
        7.10.2 Thermo Fisher Scientific Business Overview
        7.10.3 Thermo Fisher Scientific Erythropoietin Stimulating Agents Major Product Offerings
        7.10.4 Thermo Fisher Scientific Erythropoietin Stimulating Agents Revenue in Global Market (2017-2022)
        7.10.5 Thermo Fisher Scientific Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Erythropoietin Stimulating Agents Market Opportunities & Trends in Global Market
    Table 2. Erythropoietin Stimulating Agents Market Drivers in Global Market
    Table 3. Erythropoietin Stimulating Agents Market Restraints in Global Market
    Table 4. Key Players of Erythropoietin Stimulating Agents in Global Market
    Table 5. Top Erythropoietin Stimulating Agents Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Erythropoietin Stimulating Agents Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Erythropoietin Stimulating Agents Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Erythropoietin Stimulating Agents Product Type
    Table 9. List of Global Tier 1 Erythropoietin Stimulating Agents Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Erythropoietin Stimulating Agents Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Erythropoietin Stimulating Agents Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Erythropoietin Stimulating Agents Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Erythropoietin Stimulating Agents Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Erythropoietin Stimulating Agents Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Erythropoietin Stimulating Agents Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Erythropoietin Stimulating Agents Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2023-2028
    Table 30. Pfizer Corporate Summary
    Table 31. Pfizer Erythropoietin Stimulating Agents Product Offerings
    Table 32. Pfizer Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
    Table 33. Amgen Corporate Summary
    Table 34. Amgen Erythropoietin Stimulating Agents Product Offerings
    Table 35. Amgen Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
    Table 36. BioSidus Corporate Summary
    Table 37. BioSidus Erythropoietin Stimulating Agents Product Offerings
    Table 38. BioSidus Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
    Table 39. Biocon Corporate Summary
    Table 40. Biocon Erythropoietin Stimulating Agents Product Offerings
    Table 41. Biocon Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
    Table 42. Celltrion Corporate Summary
    Table 43. Celltrion Erythropoietin Stimulating Agents Product Offerings
    Table 44. Celltrion Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
    Table 45. Roche Corporate Summary
    Table 46. Roche Erythropoietin Stimulating Agents Product Offerings
    Table 47. Roche Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
    Table 48. Intas Pharmaceuticals Corporate Summary
    Table 49. Intas Pharmaceuticals Erythropoietin Stimulating Agents Product Offerings
    Table 50. Intas Pharmaceuticals Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
    Table 51. Johnson and Johnson Corporate Summary
    Table 52. Johnson and Johnson Erythropoietin Stimulating Agents Product Offerings
    Table 53. Johnson and Johnson Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
    Table 54. Teva Pharmaceutical Industries Corporate Summary
    Table 55. Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Product Offerings
    Table 56. Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
    Table 57. Thermo Fisher Scientific Corporate Summary
    Table 58. Thermo Fisher Scientific Erythropoietin Stimulating Agents Product Offerings
    Table 59. Thermo Fisher Scientific Erythropoietin Stimulating Agents Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Erythropoietin Stimulating Agents Segment by Type in 2021
    Figure 2. Erythropoietin Stimulating Agents Segment by Application in 2021
    Figure 3. Global Erythropoietin Stimulating Agents Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Erythropoietin Stimulating Agents Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Erythropoietin Stimulating Agents Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Erythropoietin Stimulating Agents Revenue in 2021
    Figure 8. By Type - Global Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
    Figure 12. US Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
    Figure 16. Germany Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 17. France Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
    Figure 24. China Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 28. India Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
    Figure 30. Brazil Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Erythropoietin Stimulating Agents Revenue Market Share, 2017-2028
    Figure 33. Turkey Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Erythropoietin Stimulating Agents Revenue, (US$, Mn), 2017-2028
    Figure 37. Pfizer Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Amgen Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. BioSidus Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Biocon Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Celltrion Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Roche Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Intas Pharmaceuticals Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Johnson and Johnson Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Teva Pharmaceutical Industries Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Thermo Fisher Scientific Erythropoietin Stimulating Agents Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
65
Frequently Asked Questions
Erythropoietin Stimulating Agents Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Erythropoietin Stimulating Agents Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Erythropoietin Stimulating Agents Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports